Literature DB >> 8395436

Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.

A Handberg1, A Vaag, J Vinten, H Beck-Nielsen.   

Abstract

Recently, we demonstrated insulin resistance due to reduced glucose storage in young relatives of Type 2 diabetic patients. To investigate whether this was associated with a defective insulin receptor kinase, we studied ten of these young (27 +/- 1 years old) non-obese glucose tolerant first degree relatives of patients with Type 2 diabetes and eight matched control subjects with no family history of diabetes. Insulin sensitivity was assessed by a hyperinsulinaemic, euglycaemic clamp. Insulin receptors were partially purified from muscle biopsies obtained in the basal and the insulin-stimulated state during the clamp. Insulin binding capacity was decreased by 28% in the relatives (p < 0.05) in the basal biopsy. Tyrosine kinase activity in the receptor preparation was decreased by 50% in both basal and insulin-stimulated biopsies from the relatives. After stimulation with insulin "in vitro", kinase activity was reduced in the relatives in basal (p < 0.005) and insulin-stimulated (p < 0.01) biopsies and also when expressed per insulin binding capacity (p approximately 0.05). Insulin stimulation of non-oxidative glucose metabolism correlated with "in vitro" insulin-stimulated tyrosine kinase activity (r = 0.61, p < 0.01) and also when expressed per binding capacity (r = 0.53, p < 0.025). We suggest that the marked defect in tyrosine kinase activity in partially purified insulin receptors from skeletal muscle is an early event in the development of insulin resistance and contributes to the pathophysiology of Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395436     DOI: 10.1007/bf00404079

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

1.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

2.  In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.

Authors:  G R Freidenberg; S L Suter; R R Henry; D Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Decreased expression of glucose transporter in muscle from insulin-resistant patients.

Authors:  G L Dohm; C W Elton; J E Friedman; P F Pilch; W J Pories; S M Atkinson; J F Caro
Journal:  Am J Physiol       Date:  1991-03

4.  Increased insulin concentrations in nondiabetic offspring of diabetic parents.

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

5.  Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans.

Authors:  B L Nyomba; V M Ossowski; C Bogardus; D M Mott
Journal:  Am J Physiol       Date:  1990-06

6.  A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus.

Authors:  B Obermaier-Kusser; M F White; D E Pongratz; Z Su; B Ermel; C Muhlbacher; H U Haring
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

7.  Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Damsbo; A Vaag; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

8.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.

Authors:  G R Freidenberg; D Reichart; J M Olefsky; R R Henry
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins.

Authors:  B Newman; J V Selby; M C King; C Slemenda; R Fabsitz; G D Friedman
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

10.  Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus.

Authors:  J Kusari; U S Verma; J B Buse; R R Henry; J M Olefsky
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more
  11 in total

1.  Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin.

Authors:  P R Pryor; S C Liu; A E Clark; J Yang; G D Holman; D Tosh
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

2.  C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation.

Authors:  J R Zierath; A Handberg; M Tally; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 3.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 4.  Membrane glycoprotein PC-1 and insulin resistance.

Authors:  I D Goldfine; B A Maddux; J F Youngren; L Frittitta; V Trischitta; G L Dohm
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity.

Authors:  L Frittitta; J Youngren; R Vigneri; B A Maddux; V Trischitta; I D Goldfine
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

6.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

7.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 8.  Modulation of insulin receptor signalling: significance of altered receptor isoform patterns and mechanism of hyperglycaemia-induced receptor modulation.

Authors:  H U Häring; M Kellerer; L Mosthaf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 9.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

10.  Insulin receptor tyrosine-kinase activity is altered in both muscle and adipose tissue from non-obese normoglycaemic insulin-resistant subjects.

Authors:  G Grasso; L Frittitta; M Anello; P Russo; G Sesti; V Trischitta
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.